基于T细胞的疗法用于治疗复发性或耐火性地幔细胞淋巴瘤
Zachary D Epstein-Peterson1,2, M Lia Palomba1,2
1Lymphoma Service, Division of Hematologic Malignancies, New York, NY.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
新的基于免疫的疗法对地幔细胞淋巴瘤 (MCL) 患者有前途,这些患者对向治疗没有反应. 本综述探讨了它们在临床实践中的作用以及改善结果的未来研究方向.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 像布鲁顿的氨酸激酶 (BTK) 和BCL2抑制剂这样的向疗法已经推进了地幔细胞淋巴瘤 (MCL) 治疗.
- 然而,并非所有患者都会反应,而且反应可能是短暂的,特别是在高风险的MCL中.
- 疾病的进展导致更短的反应时间和有限的生存率.
研究的目的:
- 审查当前针对MCL的新型免疫基础疗法的现状.
- 检查将这些药物纳入临床实践的方法.
- 找出未解答的问题,这些问题对于改善患者的治疗结果至关重要.
主要方法:
- 对MCL免疫疗法的当前文献的综述.
- 讨论临床实施策略.
- 确定关键的研究问题.
主要成果:
- 膜细胞淋巴瘤 (MCL) 对新的基于免疫的疗法表现出敏感性.
- 化学抗原受体 (CAR) -T细胞和双特异性T细胞参与者是新兴的治疗方法.
- 正在观察到有利的结果,这些药物正在被调查和实施.
结论:
- 基于免疫的疗法代表了MCL治疗的重大进步.
- 需要进一步的研究,以优化在日常实践中使用这些药物.
- 解决关键问题将提高治疗策略和MCL患者的存活率.
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
T Cell Activation and Clonal Selection
658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
658
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cytotoxic T Cells-mediated Immune Response
846
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

